Traynor Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-7,744
Closed -$768K 184
2019
Q3
$768K Sell
7,744
-1,454
-16% -$138K 0.24% 76
2019
Q2
$859K Sell
9,198
-4,492
-33% -$427K 0.28% 70
2019
Q1
$1.29M Sell
13,690
-8,893
-39% -$778K 0.43% 46
2018
Q4
$1.45M Buy
22,583
+4,772
+27% +$352K 0.6% 34
2018
Q3
$1.59M Buy
17,811
+1,738
+11% +$154K 0.52% 38
2018
Q2
$1.28M Sell
16,073
-1,301
-7% -$108K 0.47% 37
2018
Q1
$1.55M Buy
17,374
+548
+3% +$52.6K 0.63% 32
2017
Q4
$1.75M Buy
16,826
+2,278
+16% +$257K 0.75% 31
2017
Q3
$2.08M Buy
14,548
+344
+2% +$46.9K 0.99% 24
2017
Q2
$1.9M Buy
14,204
+1,209
+9% +$148K 0.94% 21
2017
Q1
$1.61M Buy
12,995
+1,206
+10% +$144K 0.9% 24
2016
Q4
$1.33M Sell
11,789
-600
-5% -$66.8K 0.88% 27
2016
Q3
$1.24M Buy
12,389
+131
+1% +$14.2K 0.88% 29
2016
Q2
$1.23M Sell
12,258
-490
-4% -$50.7K 0.96% 26
2016
Q1
$1.27M Sell
12,748
-1,870
-13% -$193K 1.02% 25
2015
Q4
$1.75M Buy
14,618
+1,435
+11% +$166K 1.26% 21
2015
Q3
$1.43M Buy
13,183
+579
+5% +$71.9K 1.23% 18
2015
Q2
$1.46M Sell
12,604
-210
-2% -$24K 1.22% 16
2015
Q1
$1.48M Buy
12,814
+1,720
+16% +$206K 1.42% 12
2014
Q4
$1.24M Buy
+11,094
New +$1.17M 1.44% 13

Other funds holding CELG

Traynor Capital Management's CELG Position: Q4 2019 in Review

Traynor Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,744 shares — an estimated $768K sold.

Traynor Capital Management first reported a position in CELG in Q4 2014 and held it in 20 quarters. The position peaked at $2.08M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Traynor Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Traynor Capital Management sold 7,744 Celgene Corp shares in Q4 2019, an estimated $768K.
  • Traynor Capital Management first reported a position in Celgene Corp in Q4 2014 and held it in 20 quarters.
  • Traynor Capital Management's Celgene Corp position peaked at $2.08M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Traynor Capital Management's 13F filing for Q4 2019, filed 24 Jan 2020.